Clinical trial
An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors
NCT05080166 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 8, 2022
- Completion date
- July 17, 2026
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lymphoma, survivorship